[Oral anticoagulation after major hip or knee replacement surgery: a process-driven managerial pharmacoeconomic analysis in German hospitals].

Der Orthopäde
T WilkeD Röleke

Abstract

The thrombin inhibitor dabigatranetexilat is used for prophylaxis of venous thromboembolism after total hip or knee replacement surgery (THR/TKR). Patients can take it orally in hospitals. In a managerial pharmacoeconomic analysis of six German acute-care hospitals and six German rehabilitation hospitals, the use of dabigatranetexilat was compared with the use of low-molecular-weight heparins. The analysis showed that the new drug led to an economic advantage for an acute-care hospital of 2.43 euro per patient per day. In a rehabilitation hospital, the use of dabigatranetexilat led to an economic advantage of 1.40 euro per patient per day. These results have direct implications for drug decisions in hospitals. To demonstrate that fact, the price difference between dabigatranetexilat and low-molecular-weight heparins was derived to lead exactly to their"economic neutrality" from the hospital's point of view.

References

Jul 10, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·H Van AkenU Tebbe
Jan 5, 2002·Der Orthopäde·F BöttnerJ Steinbeck
Aug 20, 2004·Pharmacotherapy·David Hawkins
Sep 28, 2006·PharmacoEconomics·James M Mason, Anne R Mason

❮ Previous
Next ❯

Citations

May 19, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sam Schulman, Ammar Majeed
Mar 25, 2010·Clinical Orthopaedics and Related Research·Thomas WilkeAndreas Kurth
Mar 1, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Sorrel E Wolowacz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.